Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Apdn save search
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 5.0%
H: 0.02%
C: -4.76%
first year dna financial results
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 2.02%
H: 7.92%
C: 2.17%
report year dna financial results
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 2.27%
H: 4.81%
C: -0.22%
diagnostic cancer dna order application
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
Published: 2023-11-16 (Crawled : 14:30) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 6.25%
H: 0.0%
C: -0.94%
dna application platform
Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
Published: 2023-08-23 (Crawled : 16:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -0.74%
H: 14.18%
C: 8.21%
patent mrna dna
Applied DNA Achieves Milestone for Large-Scale linearDNA™ Production, Delivers Largest Single Shipment by Volume to Date
Published: 2023-03-29 (Crawled : 13:20) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 3.64%
H: 2.63%
C: -1.75%
dna milestone
Applied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based Vaccines
Published: 2023-01-05 (Crawled : 17:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -1.23%
H: 20.31%
C: 3.12%
dna potential publication
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
Published: 2022-12-14 (Crawled : 23:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -4.76%
H: 5.0%
C: 0.0%
dna year financial results
Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022
Published: 2022-12-12 (Crawled : 17:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 2.88%
H: 9.45%
C: 3.5%
report dna year financial results
Applied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date
Published: 2022-10-10 (Crawled : 15:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -2.42%
H: 96.69%
C: 75.21%
dna order
Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
Published: 2022-09-07 (Crawled : 17:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -6.73%
H: 1.81%
C: 1.81%
global conference dna
Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health
Published: 2022-08-19 (Crawled : 14:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -6.94%
H: 38.21%
C: 22.69%
monkeypox test dna diagnostic health state virus approval
Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)
Published: 2022-08-10 (Crawled : 14:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -1.81%
H: 8.4%
C: -5.53%
dna platform
Applied DNA Biotherapeutics Subsidiary LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Development
Published: 2022-07-25 (Crawled : 13:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 1.32%
H: 0.0%
C: -11.42%
veterinary vaccine dna unique animal positive platform
Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced Linear
Published: 2022-07-22 (Crawled : 15:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 4.62%
H: 10.82%
C: 5.28%
dna
Applied DNA Launches Initiatives to Expand Awareness of LinearDNA™ Platform as an Alternative to Plasmid DNA for Therapeutic Applications, Revamps LineaRx Website
Published: 2022-06-29 (Crawled : 15:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -0.88%
H: 15.91%
C: -3.38%
dna alternative platform
U.S. Government Guidance Permits DNA Traceability and Isotopic Testing as Evidence under Uyghur Forced Labor Prevention Act
Published: 2022-06-21 (Crawled : 15:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 7.03%
H: 0.0%
C: 0.0%
dna
Applied DNA to Participate in Fireside Chat at the 34th Annual ROTH Investor Conference
Published: 2022-03-10 (Crawled : 18:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -2.98%
H: 2.63%
C: -4.39%
conference
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
Published: 2022-02-03 (Crawled : 16:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: 0.0%
H: 1.75%
C: -0.41%
financial results conference results
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
Published: 2022-01-28 (Crawled : 18:00) - biospace.com/
APDN | $0.3309 -3.56% -3.69% 30K
|
Commercial Services
|
| O: -1.18%
H: 5.65%
C: -4.76%
covid-19 covid
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.